50 related articles for article (PubMed ID: 32452658)
21. FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma.
Vaxman I; Bernstine H; Kleinstern G; Hendin N; Shimony S; Domachevsky L; Gurion R; Groshar D; Raanani P; Gafter-Gvili A
Hematol Oncol; 2019 Apr; 37(2):168-175. PubMed ID: 30734341
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients.
Elsayad K; Reinartz G; Oertel M; Rehn S; Eismann J; Scobioala S; Berssenbrügge H; Eter N; Weishaupt C; Schmidt HH; Friedrichs B; Grünewald I; Hartmann W; Lenz G; Wardelmann E; Willich N; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):117-125. PubMed ID: 31732783
[TBL] [Abstract][Full Text] [Related]
23. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Br J Haematol; 2016 Oct; 175(2):275-280. PubMed ID: 27443247
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
25. Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study.
Koh MS; Kim WS; Kim SJ; Oh SY; Yoon DH; Lee SI; Hong J; Song MK; Shin HJ; Kwon JH; Kim HJ; Do YR; Suh C; Kim HJ
Int J Hematol; 2015 Oct; 102(4):420-5. PubMed ID: 26210384
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary MALT Lymphoma has variable features on CT.
Deng W; Wan Y; Yu JQ
Sci Rep; 2019 Jun; 9(1):8657. PubMed ID: 31209274
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution.
Alderuccio JP; Zhao W; Desai A; Gallastegui N; Ramdial J; Kimble E; de la Fuente MI; Rosenblatt JD; Chapman JR; Vega F; Reis IM; Lossos IS
J Clin Oncol; 2018 Oct; ():JCO1800138. PubMed ID: 30312133
[TBL] [Abstract][Full Text] [Related]
28. Clinical manifestations of pulmonary mucosa-associated lymphoid tissue lymphoma: single-center experience with 18 patients.
Zhao S; Zhang L; Gu Z; Zhu C; Fang S; Yang N; Wang F; Guan L; Luo L; Gao C
Onco Targets Ther; 2018; 11():555-561. PubMed ID: 29416356
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary mucosa-associated lymphoid tissue lymphoma:
Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
[TBL] [Abstract][Full Text] [Related]
30. A MALT lymphoma prognostic index.
Thieblemont C; Cascione L; Conconi A; Kiesewetter B; Raderer M; Gaidano G; Martelli M; Laszlo D; Coiffier B; Lopez Guillermo A; Torri V; Cavalli F; Johnson PW; Zucca E
Blood; 2017 Sep; 130(12):1409-1417. PubMed ID: 28720586
[TBL] [Abstract][Full Text] [Related]
31. Treatment outcomes in patients with extranodal marginal zone B-cell lymphoma of the lung.
Lee H; Yang B; Nam B; Jeong BH; Shin S; Zo JI; Shim YM; Kwon OJ; Lee KS; Kim H
J Thorac Cardiovasc Surg; 2017 Jul; 154(1):342-349. PubMed ID: 28457544
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
[TBL] [Abstract][Full Text] [Related]
33. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.
Zucca E; Bertoni F
Blood; 2016 Apr; 127(17):2082-92. PubMed ID: 26989205
[TBL] [Abstract][Full Text] [Related]
34. Histologic transformation in marginal zone lymphomas†.
Conconi A; Franceschetti S; Aprile von Hohenstaufen K; Margiotta-Casaluci G; Stathis A; Moccia AA; Bertoni F; Ramponi A; Mazzucchelli L; Cavalli F; Gaidano G; Zucca E
Ann Oncol; 2015 Nov; 26(11):2329-35. PubMed ID: 26400898
[TBL] [Abstract][Full Text] [Related]
35. A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).
Sammassimo S; Pruneri G; Andreola G; Montoro J; Steffanoni S; Nowakowski GS; Gandini S; Negri M; Habermann TM; Raderer M; Li ZM; Zinzani PL; Adam P; Zucca E; Martinelli G
Hematol Oncol; 2016 Dec; 34(4):177-183. PubMed ID: 26152851
[TBL] [Abstract][Full Text] [Related]
36. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.
Okamura I; Imai H; Mori K; Ogura K; Isoda A; Mihara K; Matsumoto M; Saito R; Takahashi T; Ikeda T
Int J Hematol; 2015 Jan; 101(1):46-51. PubMed ID: 25378228
[TBL] [Abstract][Full Text] [Related]
37. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.
Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M
Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe.
Adam P; Czapiewski P; Colak S; Kosmidis P; Tousseyn T; Sagaert X; Boudova L; Okoń K; Morresi-Hauf A; Agostinelli C; Pileri S; Pruneri G; Martinelli G; Du MQ; Fend F
Br J Haematol; 2014 Mar; 164(6):804-10. PubMed ID: 24372375
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma.
Borie R; Wislez M; Thabut G; Antoine M; Rabbat A; Couderc LJ; Monnet I; Nunes H; Blanc FX; Mal H; Bergeron A; Dusser D; Israël-Biet D; Crestani B; Cadranel J
Eur Respir J; 2009 Dec; 34(6):1408-16. PubMed ID: 19541720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
